Search

Your search keyword '"Forbess, Lindsy"' showing total 122 results

Search Constraints

Start Over You searched for: Author "Forbess, Lindsy" Remove constraint Author: "Forbess, Lindsy"
122 results on '"Forbess, Lindsy"'

Search Results

2. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

3. The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial

4. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

6. Magnetic resonance multitasking for multidimensional assessment of cardiovascular system: Development and feasibility study on the thoracic aorta

7. Arterial lesions in giant cell arteritis: A longitudinal study.

8. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

9. Identification of susceptibility loci for Takayasu arteritis through a large multi-ancestral genome-wide association study

11. Contributors

13. The impact of treatment with avacopan on health-related quality of life in antineutrophil cytoplasmic antibody-associated vasculitis: a post-hoc analysis of data from the ADVOCATE trial

14. A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

17. Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial

18. A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility

20. Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trial

22. Contributors

26. Neutrophils Contribute to ER Stress in Lung Epithelial Cells in the Pristane-Induced Diffuse Alveolar Hemorrhage Mouse Model

28. Neutrophils contribute to ER stress in lung epithelial cells in the pristane-induced diffuse alveolar hemorrhage mouse model

29. The effects of plasma exchange and glucocorticoids on early kidney function among patients with ANCA-associated vasculitis in the PEXIVAS trial

30. Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

31. MR Multitasking for Multi-dimensional Assessment of Cardiovascular System (MT-MACS): Development and Feasibility Study on the Thoracic Aorta

35. Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis

36. Contributors

38. 148. SHORT-FORM 36 AS A MEASURE OF HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH GIANT CELL ARTERITIS

39. Clinical Manifestations and Long‐Term Outcomes of Eosinophilic Granulomatosis With Polyangiitis in North America.

40. MicroRNA-302d targets IRF9 to regulate the IFN-induced gene expression in SLE

41. Sequence‐Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2.

42. IL-16/miR-125a axis controls neutrophil recruitment in pristane-induced lung inflammation

43. A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility

44. Contributors

45. A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

47. Practice Patterns of ANCA-Associated Vasculitis: Exploring Differences Among Subspecialties at a Single Academic Medical Center

48. A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility

49. A Large-Scale Genetic Analysis Reveals a Strong Contribution of the HLA Class II Region to Giant Cell Arteritis Susceptibility

50. A Randomized, Double-Blind Trial of Abatacept (CTLA-4Ig) for the Treatment of Giant Cell Arteritis.

Catalog

Books, media, physical & digital resources